These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2200108)

  • 41. Randomized study of interferon beta-1a, low-dose azathioprine, and low-dose corticosteroids in multiple sclerosis.
    Havrdova E; Zivadinov R; Krasensky J; Dwyer MG; Novakova I; Dolezal O; Ticha V; Dusek L; Houzvickova E; Cox JL; Bergsland N; Hussein S; Svobodnik A; Seidl Z; Vaneckova M; Horakova D
    Mult Scler; 2009 Aug; 15(8):965-76. PubMed ID: 19465443
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Long-term effects of glatiramer acetate in multiple sclerosis].
    Brochet B
    Rev Neurol (Paris); 2008 Nov; 164(11):917-26. PubMed ID: 18790510
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cyclosporine trials in diabetes: updated results of the French experience.
    Assan R; Feutren G; Sirmai J
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):178-83. PubMed ID: 3289203
    [No Abstract]   [Full Text] [Related]  

  • 44. [Use of magnetic resonance imaging in the diagnosis and prognosis of multiple sclerosis].
    Zivadinov R; Sepcić J
    Lijec Vjesn; 2006; 128(9-10):295-308. PubMed ID: 17128669
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Azathioprine for multiple sclerosis.
    Casetta I; Iuliano G; Filippini G
    J Neurol Neurosurg Psychiatry; 2009 Feb; 80(2):131-2; discussion 132. PubMed ID: 19151017
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interferon beta-1b in secondary progressive multiple sclerosis--outline of the clinical trial.
    Polman CH; Dahlke F; Thompson AJ; Ghazi M; Kappos L; Miltenburger C; Pozilli C
    Mult Scler; 1995; 1 Suppl 1():S51-4. PubMed ID: 9345400
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Overview of azathioprine treatment in multiple sclerosis.
    Yudkin PL; Ellison GW; Ghezzi A; Goodkin DE; Hughes RA; McPherson K; Mertin J; Milanese C
    Lancet; 1991 Oct; 338(8774):1051-5. PubMed ID: 1681364
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Therapeutic trials in multiple sclerosis.
    Noseworthy JH; Seland TP; Ebers GC
    Can J Neurol Sci; 1984 Aug; 11(3):355-62. PubMed ID: 6205737
    [No Abstract]   [Full Text] [Related]  

  • 49. [Treatment of multiple sclerosis with levamisole and azathioprine. Comparison of the effectiveness, of an 'immunostimulative' and 'immunosuppressive' treatment (author's transl)].
    Patzold U; Haller P; Haas J; Pocklington P; Deicher H
    Nervenarzt; 1978 May; 49(5):285-94. PubMed ID: 673085
    [No Abstract]   [Full Text] [Related]  

  • 50. Immunoadsorption (IA) versus plasma exchange (PE) in multiple sclerosis--first results of a double blind controlled trial.
    Schmitt E; Behm E; Buddenhagen F; Ernst B; Hitzschke B; Kracht M; Korten G; Kundt G; Meyer-Rienecker H; Osten B
    Prog Clin Biol Res; 1990; 337():289-92. PubMed ID: 2191322
    [No Abstract]   [Full Text] [Related]  

  • 51. [Treatment of multiple sclerosis by Azathioprine. About 77 cases studied during 10 years (author's transl)].
    Aimard G; Confavreux C; Trouillas P; Devic M
    Rev Neurol (Paris); 1978 Mar; 134(3):215-22. PubMed ID: 360353
    [No Abstract]   [Full Text] [Related]  

  • 52. Cyclosporin A curtails the progression of free light chain synthesis in the CSF of patients with multiple sclerosis.
    McLean BN; Rudge P; Thompson EJ
    J Neurol Neurosurg Psychiatry; 1989 Apr; 52(4):529-31. PubMed ID: 2500497
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Double blind controlled randomized study on azathioprine efficacy in multiple sclerosis. Preliminary results.
    Milanese C; La Mantia L; Salmaggi A; Campi A; Bortolami C; Tajoli L; Nespolo A; Corridori F
    Ital J Neurol Sci; 1988 Feb; 9(1):53-7. PubMed ID: 3281916
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Intrahepatic cholestasis, an allergic reaction in azathioprine therapy?].
    Haas J; Patzold U; Stamm T
    Dtsch Med Wochenschr; 1978 Oct; 103(40):1576-7. PubMed ID: 699768
    [No Abstract]   [Full Text] [Related]  

  • 55. [Preliminary results of imurek treatment of multiple sclerosis].
    Müller J; Kreiner R; Sauermann W
    Psychiatr Neurol Med Psychol (Leipz); 1976 Dec; 28(12):755-61. PubMed ID: 1019278
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Double-blind controlled trial of azathioprine in the treatment of multiple sclerosis.
    J Neurol Neurosurg Psychiatry; 1987 Oct; 50(10):1387. PubMed ID: 3316505
    [No Abstract]   [Full Text] [Related]  

  • 57. Cyclosporine and multiple sclerosis.
    Pender MP
    Ann Neurol; 1991 Feb; 29(2):226. PubMed ID: 2012393
    [No Abstract]   [Full Text] [Related]  

  • 58. The efficacy of azathioprine in relapsing-remitting multiple sclerosis.
    Goodkin DE; Bailly RC; Teetzen ML; Hertsgaard D; Beatty WW
    Neurology; 1991 Jan; 41(1):20-5. PubMed ID: 1985289
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Secondary myelodysplastic syndrome following long-term treatment with azathioprine in patients with multiple sclerosis.
    Putzki N; Knipp S; Ramczykowski T; Vago S; Germing U; Diener HC; Limmroth V
    Mult Scler; 2006 Jun; 12(3):363-6. PubMed ID: 16764353
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immunosuppressive treatments in MS--side effects from azathioprine.
    Craner MJ; Zajicek JP
    J Neurol; 2001 Jul; 248(7):625-6. PubMed ID: 11518009
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.